Impact of PACAP and PAC1 receptor deficiency on the neurochemical and behavioral effects of acute and chronic restraint stress in male C57BL/6 mice

Abstract Acute restraint stress (ARS) for 3 h causes corticosterone (CORT) elevation in venous blood, which is accompanied by Fos up-regulation in the paraventricular nucleus (PVN) of male C57BL/6 mice. CORT elevation by ARS is attenuated in PACAP-deficient mice, but unaffected in PAC1-deficient mice. Correspondingly, Fos up-regulation by ARS is greatly attenuated in PACAP-deficient mice, but much less so in PAC1-deficient animals. We noted that both PACAP- and PAC1-deficiency greatly attenuate CORT elevation after ARS when CORT measurements are performed on trunk blood following euthanasia by abrupt cervical separation: this latter observation is of critical importance in assessing the role of PACAP neurotransmission in ARS, based on previous reports in which serum CORT was sampled from trunk blood. Seven days of chronic restraint stress (CRS) induces non-habituating CORT elevation, and weight loss consequent to hypophagia, in wild-type male C57BL/6 mice. Both CORT elevation and weight loss following 7-day CRS are severely blunted in PACAP-deficient mice, but only slightly in PAC1-deficient mice. However, longer periods of daily restraint (14–21 days) resulted in sustained weight loss and elevated CORT in wild-type mice, and these effects of long-term chronic stress were attenuated or abolished in both PACAP- and PAC1-deficient mice. We conclude that while a PACAP receptor in addition to PAC1 may mediate some of the PACAP-dependent central effects of ARS and short-term (<7 days) CRS on the hypothalamo-pituitary-adrenal (HPA) axis, the PAC1 receptor plays a prominent role in mediating PACAP-dependent HPA axis activation, and hypophagia, during long-term (>7 days) CRS.

[1]  A. Howard,et al.  PAC1 receptor antagonism in the bed nucleus of the stria terminalis (BNST) attenuates the endocrine and behavioral consequences of chronic stress , 2014, Psychoneuroendocrinology.

[2]  M. Ago,et al.  Temporal changes of the adrenal endocrine system in a restraint stressed mouse and possibility of postmortem indicators of prolonged psychological stress. , 2014, Legal medicine.

[3]  D. Toufexis,et al.  PACAP in the BNST Produces Anorexia and Weight Loss in Male and Female Rats , 2014, Neuropsychopharmacology.

[4]  P. Cottone,et al.  CRF Mediates the Anxiogenic and Anti-Rewarding, But Not the Anorectic Effects of PACAP , 2013, Neuropsychopharmacology.

[5]  M. Herkenham,et al.  PACAP-deficient mice show attenuated corticosterone secretion and fail to develop depressive behavior during chronic social defeat stress , 2013, Psychoneuroendocrinology.

[6]  L. Eiden,et al.  PACAP controls adrenomedullary catecholamine secretion and expression of catecholamine biosynthetic enzymes at high splanchnic nerve firing rates characteristic of stress transduction in male mice. , 2013, Endocrinology.

[7]  M. Palkovits,et al.  Effect of lesions of A5 or A7 noradrenergic cell group or surgical transection of brainstem catecholamine pathways on plasma catecholamine levels in rats injected subcutaneously by formalin. , 2012, General physiology and biophysics.

[8]  M. Cooper,et al.  Overlapping neurobiology of learned helplessness and conditioned defeat: Implications for PTSD and mood disorders , 2012, Neuropharmacology.

[9]  G. Aguilera,et al.  Pituitary Adenylate Cyclase‐Activating Polypeptide Controls Stimulus‐Transcription Coupling in the Hypothalamic‐Pituitary‐Adrenal Axis to Mediate Sustained Hormone Secretion During Stress , 2011, Journal of neuroendocrinology.

[10]  M. Tanida,et al.  PACAP centrally mediates emotional stress-induced corticosterone responses in mice , 2011, Stress.

[11]  L. Eiden,et al.  PACAP: a master regulator of neuroendocrine stress circuits and the cellular stress response , 2011, Annals of the New York Academy of Sciences.

[12]  B. Bradley,et al.  Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor , 2011, Nature.

[13]  H. Steinbusch,et al.  Update in the methodology of the chronic stress paradigm: internal control matters , 2011, Behavioral and Brain Functions.

[14]  W. Falls,et al.  Roles for Pituitary Adenylate Cyclase-Activating Peptide (PACAP) Expression and Signaling in the Bed Nucleus of the Stria Terminalis (BNST) in Mediating the Behavioral Consequences of Chronic Stress , 2010, Journal of Molecular Neuroscience.

[15]  L. Eiden,et al.  Stress hormone synthesis in mouse hypothalamus and adrenal gland triggered by restraint is dependent on pituitary adenylate cyclase-activating polypeptide signaling , 2010, Neuroscience.

[16]  L. Eiden,et al.  PACAP-cytokine interactions govern adrenal neuropeptide biosynthesis after systemic administration of LPS , 2010, Neuropharmacology.

[17]  B. Kuri,et al.  PACAP regulates immediate catecholamine release from adrenal chromaffin cells in an activity‐dependent manner through a protein kinase C‐dependent pathway , 2009, Journal of neurochemistry.

[18]  W. Falls,et al.  Chronic stress increases pituitary adenylate cyclase-activating peptide (PACAP) and brain-derived neurotrophic factor (BDNF) mRNA expression in the bed nucleus of the stria terminalis (BNST): Roles for PACAP in anxiety-like behavior , 2009, Psychoneuroendocrinology.

[19]  C J Barnum,et al.  Adaptation in the Corticosterone and Hyperthermic Responses to Stress Following Repeated Stressor Exposure , 2007, Journal of neuroendocrinology.

[20]  H. Suh,et al.  The effect of single or repeated restraint stress on several signal molecules in paraventricular nucleus, arcuate nucleus and locus coeruleus , 2006, Neuroscience.

[21]  L. Halvorson,et al.  Pituitary adenylate cyclase-activating polypeptide (PACAP) mimics neuroendocrine and behavioral manifestations of stress: Evidence for PKA-mediated expression of the corticotropin-releasing hormone (CRH) gene. , 2005, Brain research. Molecular brain research.

[22]  S. Norrholm,et al.  Behavioral effects of local microinfusion of pituitary adenylate cyclase activating polypeptide (PACAP) into the paraventricular nucleus of the hypothalamus (PVN) , 2005, Regulatory Peptides.

[23]  L. Eiden,et al.  Role of Protein Kinases in Neuropeptide Gene Regulation by PACAP in Chromaffin Cells , 2002, Annals of the New York Academy of Sciences.

[24]  W. Young,et al.  Pituitary adenylate cyclase-activating polypeptide is a sympathoadrenal neurotransmitter involved in catecholamine regulation and glucohomeostasis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[25]  J. Miyazaki,et al.  Altered psychomotor behaviors in mice lacking pituitary adenylate cyclase-activating polypeptide (PACAP) , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[26]  R. Maldonado,et al.  Altered emotional behavior in PACAP-type-I-receptor-deficient mice. , 2001, Brain research. Molecular brain research.

[27]  V. Grinevich,et al.  Effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on corticotropin-releasing hormone (CRH) gene expression in the rat hypothalamic paraventricular nucleus , 1997, Brain Research.

[28]  I. Kopin,et al.  Plasma catecholamine concentrations in unanesthetized rats during sleep, wakefulness, immobilization and after decapitation. , 1977, The Journal of pharmacology and experimental therapeutics.